Oral self-management of palbociclib (Ibrance®) using mobile technology protocol Journal Article
| Authors: | Mazzella Ebstein, A. M.; Barton-Burke, M.; Anthony, V.; Smith, A.; Zhang, Z.; Robson, M. |
| Article Title: | Oral self-management of palbociclib (Ibrance®) using mobile technology protocol |
| Abstract: | Aim: This study will test the feasibility and effectiveness of mobile technology intervention on the patients’ self-management of oral anticancer medication. Secondary objectives include acceptability, the usefulness of text messages, and satisfaction by participants and nurses. Methods: This prospective two-arm study will recruit patients (N = 220) with metastatic breast cancer and initiating treatment with palbociclib (Ibrance ®). Allowing for attrition, patients will be randomized into the control (N = 100) or intervention (N = 100) group. Unidirectional text message reminders will be sent during the treatment cycle through a secure web application using the patient's smartphone. Self-reported survey responses will be collected at three time points; at consent, end of treatment cycles, and the follow-up clinic visit and include a demographic questionnaire, the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire, Post study questionnaire and the R-15 Patient Satisfaction Questionnaire. Nurses providing care for study patients will complete the Adaptation of Stamps Nurse Workload questionnaire. Data will be analysed an intent-to-treat analysis comparing the two arms. Study approval was obtained in December 2019 and funded in January 2020. Discussion: Smartphones are globally available and have text messaging capability which is increasingly being used as an intervention in healthcare studies. This study will test a low-cost, nurse-led intervention that enhances the patient's experience with oral anti-cancer medications, improves access to care, reduces costs, and improves the satisfaction of nurses caring for oncology patients. Impact: Despite the ease of administering oral anti-cancer medications, oncology patients maynot take them as prescribed and consequently, these factors affect patient outcomes and disease control. Given the importance of taking oral anti-cancer medications and the difficulties patients experience in achieving it, the effective use of mobile technology interventions can actively engage patients in their care and improve medication self-management of anticancer treatment regimens. © 2020 John Wiley & Sons Ltd |
| Keywords: | nursing; nurses; text messaging; cancer; mobile technology; medication self-management; midwives |
| Journal Title: | Journal of Advanced Nursing |
| Volume: | 77 |
| Issue: | 3 |
| ISSN: | 0309-2402 |
| Publisher: | John Wiley & Sons |
| Date Published: | 2021-03-01 |
| Start Page: | 1556 |
| End Page: | 1566 |
| Language: | English |
| DOI: | 10.1111/jan.14659 |
| PROVIDER: | scopus |
| PUBMED: | 33245144 |
| PMCID: | PMC8454747 |
| DOI/URL: | |
| Notes: | Article -- Export Date: 1 March 2021 -- Source: Scopus |
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
-
430Zhang -
681Robson -
13Smith -
43Barton-Burke -
4Anthony
Related MSK Work